Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)

SHA:688266 Revenue

Suzhou Zelgen Biopharmaceuticals had revenue of 167.64M CNY in the quarter ending March 31, 2025, with 54.87% growth. This brings the company's revenue in the last twelve months to 592.35M, up 53.23% year-over-year. In the year 2024, Suzhou Zelgen Biopharmaceuticals had annual revenue of 532.95M with 37.91% growth.

• Revenue (ttm): 592.35M
• Revenue Growth: +53.23%
• P/S Ratio: 50.58
• Revenue / Employee: 650.94K
• Employees: 910
• Market Cap: 29.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	532.95M	146.52M	37.91%
Dec 31, 2023	386.44M	84.13M	27.83%
Dec 31, 2022	302.31M	111.94M	58.81%
Dec 31, 2021	190.36M	162.70M	588.19%
Dec 31, 2020	27.66M	-	-